Loading organizations...
Imprivata, based in Lexington, Massachusetts, provides digital identity security solutions that secure access to desktops, networks, applications, and sensitive data. Their platform leverages single sign-on, multifactor authentication, and privileged access management to enable seamless, passwordless access, primarily for shared devices in high-stakes environments. Serving over 2,000 healthcare organizations and 6 million users across 39 countries, the company maintains approximately 957 employees and generates $201 million in revenue. Imprivata has secured over $881 million in total funding and was acquired by private equity firm Thoma Bravo for $544 million in 2016. Under CEO Fran Rosch, the organization has expanded its capabilities through strategic acquisitions. Imprivata was founded in 2002 by David Ting and Phil Scarfo. Its business model centers on sells IT security software platform via subscriptions or licenses to enterprise customers, acquired by private equity firm Thoma Bravo in 2016.
Imprivata has raised $45.0M across 4 funding rounds.
Imprivata has raised $45.0M in total across 4 funding rounds.
Imprivata has raised $45.0M in total across 4 funding rounds.
Imprivata's investors include ACME Capital, Bessemer Venture Partners, DN Capital, General Catalyst, Highland Capital Partners, Polaris Partners, Sapphire Ventures, Venrock.
Imprivata has raised $45.0M across 4 funding rounds. Most recently, it raised $15.0M Series C in April 2008.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2008 | $15M Series C | — | ACME Capital, Bessemer Venture Partners, DN Capital, General Catalyst, Highland Capital Partners, Polaris Partners, Sapphire Ventures, Venrock | Announced |
| Feb 1, 2006 | $12M Series B | — | General Catalyst, Highland Capital Partners, Polaris Partners | Announced |
| May 1, 2005 | $4M Series A | — | General Catalyst, Highland Capital Partners, Polaris Partners | Announced |
| Apr 1, 2002 | $14M Series A | — | General Catalyst, Highland Capital Partners, Polaris Partners | Announced |
Imprivata is a digital identity security company that builds a unified platform of interoperable access management and privileged access security solutions, including passwordless single sign-on (SSO), multi-factor authentication (MFA), mobile access, third-party access control, and AI-powered access analytics.[1][2][3] It primarily serves healthcare organizations and other mission-critical industries like manufacturing, enabling frictionless, secure workflows for clinicians, frontline workers, and administrators on shared devices, workstations, and operational technology, solving problems like password fatigue, cyber threats, compliance burdens, and workflow disruptions that hinder patient care or production.[1][3][7] With over 20 years of experience, Imprivata powers organizations in 45+ countries, reducing total cost of ownership while boosting productivity and security, backed by strategic acquisitions and ownership by Thoma Bravo since 2016.[2][4][5]
Imprivata was founded in 2000 by David Ting and Phil Scarfo, who developed identity management technology at Polaroid Corporation’s small business incubator, securing initial funding for biometrics-focused innovations like fingerprint and facial recognition.[4][5] The company shipped its first product, the OneSign Enterprise Single Sign-On appliance, in 2004, gaining traction for multi-app access in healthcare and expanding to Europe in 2006 amid recognition for Ting as a top CTO.[4][5] Pivotal moments included the 2009 HITECH Act-driven pivot to HIPAA-compliant solutions, acquisitions like IdentiPHI (2009) for biometrics and HT Systems (2015) for expanded capabilities, a 2014 NYSE IPO, and Thoma Bravo's $544 million acquisition in 2016 under CEO Omar Hussain.[4][5] Recent growth involved buying GroundControl (2019) for mobile, FairWarning (2020) for risk analytics, Xton Technologies (2021) for privileged access management, and SecureLink to enhance third-party controls.[4][5]
Imprivata rides the wave of zero-trust security and digital identity convergence in healthcare, where EHR adoption, mobile devices, IoT-connected medical equipment, and third-party vendors amplify cyber vulnerabilities amid regulations like HIPAA and HITECH.[5][6][7] Timing aligns with post-2020 accelerations in remote/hybrid work, AI-driven threat detection, and mobile proliferation—only 13% of customers currently use its mobile tools, signaling untapped growth in device checkout for shifts and monitoring MRI/vitals machines.[6] Market forces like rising ransomware attacks on hospitals and demands for workflow efficiency favor Imprivata, as it influences the ecosystem by redefining access as "invisible" via integrated platforms, enabling data science for risk-based access (e.g., UABA—User, Application, Behavior Analytics) and setting standards for secure, passwordless operations in mission-critical environments.[1][6]
Imprivata is poised to dominate digital identity in healthcare through platform unification, with milestones like integrated PAM, mobile, and AI analytics driving revenue as medical IoT and vendor access explode.[6][8] Trends like AI risk scoring, expansion to manufacturing/production, and zero-trust mandates will propel growth, potentially via further acquisitions or Thoma Bravo-fueled scaling.[5][6] Its influence may evolve from niche SSO leader to ecosystem orchestrator, embedding security in every device and workflow—reinforcing its promise of simple, secure access that powers life- and mission-critical seconds.[1]
